Inconsistency of Synergy Between the β-Lactamase Inhibitor CP-45,899 and β-Lactam Antibiotics Against Multiply Drug-Resistant Enterobacteriaceae and Pseudomonas Species

Ítems similars

• CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization
  per: English, Arthur R., et al.
  Publicat: (1978)
• Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
  per: Yu, P K, et al.
  Publicat: (1981)
• Treatment of Infections Caused by Ampicillin-Resistant Pathogens with a Combination of Ampicillin and CP-45,899
  per: Plouffe, Joseph F.
  Publicat: (1982)
• CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
  per: Retsema, J A, et al.
  Publicat: (1980)
• Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
  per: Marshall, Steven, et al.
  Publicat: (2017)